Eu Ivdd Eu Ivd Annex 2 List B On The Market 🇹🇼 Taiwan

Soludiab

Tyson Bioresearch, Inc. · 🇹🇼 Taiwan
Devices (same UDI-DI)
1
Certificates
1
Countries
0
Notified Bodies
1

Basic Information

Primary DI
D-T05H7990073KNX5
Basic UDI-DI Code
B-T05H7990073KNX5
Reference
LGLMV-02
Device Types
None provided
Regulation
Eu Ivdd
Classification
Eu Ivd Annex 2 List B
Status
On The Market

Additional Description

The LGLMV-02 Blood Glucose Monitoring System is intended for use in the quantitatively measurement of glucose (sugar) in venous blood and fresh capillary whole blood. Capillary whole blood may be drawn from the fingertip, palm and the forearm. It is not intended for neonatal testing. The BRLMV-BT-01 Blood Glucose Test Strips are for testing outside the body (in vitro diagnostic use). The LGLMV-02 Blood Glucose Monitoring System is intended for use at home (Over the Counter [OTC]) by persons with diabetes, or in clinical setting by healthcare professionals as an aid in monitoring the effectiveness of diabetes control. It is not intended for the diagnosis of or screening for diabetes mellitus. The alternative site testing in the systems can be used only during steady state blood glucose conditions.

CND Nomenclature Codes

Code Description
W0201060102 BLOOD GLUCOSE METERS

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) C-02-1073-797-22

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Annex 2 List B) and regulation (EU IVDD).

View all